US Patent 10227625 Methods of modifying eukaryotic cells
Patent 10227625 was granted and assigned to Regeneron Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10227625 Methods of modifying eukaryotic cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.